158 related articles for article (PubMed ID: 36780738)
1. Multi-reader evaluation of different image quality scoring systems in prostate MRI.
Hötker AM; Njoh S; Hofer LJ; Held U; Rupp NJ; Ghafoor S; Stocker D; Eberli D; Donati OF
Eur J Radiol; 2023 Apr; 161():110733. PubMed ID: 36780738
[TBL] [Abstract][Full Text] [Related]
2. Bridging the experience gap in prostate multiparametric magnetic resonance imaging using artificial intelligence: A prospective multi-reader comparison study on inter-reader agreement in PI-RADS v2.1, image quality and reporting time between novice and expert readers.
Forookhi A; Laschena L; Pecoraro M; Borrelli A; Massaro M; Dehghanpour A; Cipollari S; Catalano C; Panebianco V
Eur J Radiol; 2023 Apr; 161():110749. PubMed ID: 36812699
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for prostate cancer in men with false-negative mpMRI: A retrospective single center cohort study of image quality scores and clinical parameters.
Pausch AM; Ghafoor S; Kluckert J; Rupp NJ; Eberli D; Hötker AM
Eur J Radiol; 2024 Jan; 170():111227. PubMed ID: 38039782
[TBL] [Abstract][Full Text] [Related]
4. Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population.
Pötsch N; Rainer E; Clauser P; Vatteroni G; Hübner N; Korn S; Shariat SF; Helbich TH; Baltzer PAT
Eur J Radiol; 2022 Sep; 154():110431. PubMed ID: 35803101
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the PI-RADS 2.1 scoring system to PI-RADS 2.0: Impact on diagnostic accuracy and inter-reader agreement.
Hötker AM; Blüthgen C; Rupp NJ; Schneider AF; Eberli D; Donati OF
PLoS One; 2020; 15(10):e0239975. PubMed ID: 33017413
[TBL] [Abstract][Full Text] [Related]
6. Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy.
Brembilla G; Lavalle S; Parry T; Cosenza M; Russo T; Mazzone E; Pellegrino F; Stabile A; Gandaglia G; Briganti A; Montorsi F; Esposito A; De Cobelli F
Eur J Radiol; 2023 Jul; 164():110849. PubMed ID: 37141845
[TBL] [Abstract][Full Text] [Related]
7. Prostate MRI quality: clinical impact of the PI-QUAL score in prostate cancer diagnostic work-up.
Karanasios E; Caglic I; Zawaideh JP; Barrett T
Br J Radiol; 2022 May; 95(1133):20211372. PubMed ID: 35179971
[TBL] [Abstract][Full Text] [Related]
8. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.
Schimmöller L; Quentin M; Arsov C; Lanzman RS; Hiester A; Rabenalt R; Antoch G; Albers P; Blondin D
Eur Radiol; 2013 Nov; 23(11):3185-90. PubMed ID: 23756958
[TBL] [Abstract][Full Text] [Related]
9. Inter-reader agreement of the prostate imaging quality (PI-QUAL) score for basic readers in prostate MRI: A multi-center study.
Basar Y; Alis D; Seker ME; Kartal MS; Guroz B; Arslan A; Sirolu S; Kurtcan S; Denizoglu N; Karaarslan E
Eur J Radiol; 2023 Aug; 165():110923. PubMed ID: 37320883
[TBL] [Abstract][Full Text] [Related]
10. Audit of cancer yields after prostate MRI using both the PI-RADS version 2 and Likert scoring systems.
Sokhi HK; Wilson A; Pindoria N; McNamara C; Padhani AR; Meer Z; Pope A
Clin Radiol; 2022 Jul; 77(7):541-547. PubMed ID: 35570157
[TBL] [Abstract][Full Text] [Related]
11. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
[TBL] [Abstract][Full Text] [Related]
12. Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.
Giganti F; Dinneen E; Kasivisvanathan V; Haider A; Freeman A; Kirkham A; Punwani S; Emberton M; Shaw G; Moore CM; Allen C
Eur Radiol; 2022 Feb; 32(2):879-889. PubMed ID: 34327583
[TBL] [Abstract][Full Text] [Related]
13. Inter-reader variability and reproducibility of the PI-QUAL score in a multicentre setting.
Fleming H; Dias AB; Talbot N; Li X; Corr K; Haider MA; Ghai S
Eur J Radiol; 2023 Nov; 168():111091. PubMed ID: 37717419
[TBL] [Abstract][Full Text] [Related]
14. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I
World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003
[TBL] [Abstract][Full Text] [Related]
15. A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection.
Wajswol E; Winoker JS; Anastos H; Falagario U; Okhawere K; Martini A; Treacy PJ; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR
BJU Int; 2020 Apr; 125(4):531-540. PubMed ID: 31762182
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.
Chu CE; Cowan JE; Lonergan PE; Washington SL; Fasulo V; de la Calle CM; Shinohara K; Westphalen AC; Carroll PR
Eur Urol Oncol; 2022 Oct; 5(5):537-543. PubMed ID: 33483265
[TBL] [Abstract][Full Text] [Related]
17. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
[TBL] [Abstract][Full Text] [Related]
18. Assessment of PI-RADS v2 for the Detection of Prostate Cancer.
Kasel-Seibert M; Lehmann T; Aschenbach R; Guettler FV; Abubrig M; Grimm MO; Teichgraeber U; Franiel T
Eur J Radiol; 2016 Apr; 85(4):726-31. PubMed ID: 26971415
[TBL] [Abstract][Full Text] [Related]
19. Impact of Clinical History on Maximum PI-RADS Version 2 Score: A Six-Reader 120-Case Sham History Retrospective Evaluation.
Shankar PR; Kaza RK; Al-Hawary MM; Masch WR; Curci NE; Mendiratta-Lala M; Sakala MD; Johnson TD; Davenport MS
Radiology; 2018 Jul; 288(1):158-163. PubMed ID: 29664338
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
